Glutamate-based Therapies for Psychiatric Disorders /
Autor Corporativo: | |
---|---|
Otros Autores: | |
Formato: | eBook |
Lenguaje: | English |
Publicado: |
Basel :
Birkhäuser Basel : Imprint: Birkhäuser,
2010.
|
Edición: | 1st ed. 2010. |
Colección: | Milestones in Drug Therapy,
|
Materias: |
Tabla de Contenidos:
- N-Methyl-d-Aspartate (NMDA) Antagonists for the Treatment of Depression
- Ionic Glutamate Modulators in Depression (Zinc, Magnesium)
- Positive Allosteric Modulation of AMPA Receptors: A Novel Potential Antidepressant Therapy
- Glutamatergic Modulators for the Treatment of Major Depressive Disorder: Metabotropic Glutamate Receptors
- Positive Modulation of AMPA Receptors as a Broad-Spectrum Strategy for Treating Neuropsychiatric Disorders
- Activation of Group II Metabotropic Glutamate Receptors (mGluR2 and mGluR3) as a Novel Approach for Treatment of Schizophrenia
- mGluR1 Negative Allosteric Modulators: An Alternative Metabotropic Approach for the Treatment of Schizophrenia
- Metabotropic Glutamate Receptors as Targets for the Treatment of Drug and Alcohol Dependence
- Metabotropic Approaches to Anxiety.